📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Chemplast Sanmar Q3 FY26: Revenue Falls 21% to ₹835 Cr with ₹119 Cr Net Loss
Chemplast Sanmar reported a challenging Q3 FY26 with consolidated revenues declining 21% YoY to ₹835 crores and a net loss of ₹119 crores. The performance was hit by a combination of weather-related production disruptions, pricing pressure from imports, and regulatory setbacks regarding anti-dumping duties. Despite the loss, management highlighted a recovery in PVC prices starting January 2026 and the positive impact of China withdrawing its 13% export tax rebate. The company is also undergoing a leadership transition, with MD Ramkumar Shankar stepping down in April 2026.
Key Highlights
Consolidated revenue dropped 21% YoY to ₹835 crores, leading to a net loss of ₹119 crores for the quarter.
Specialty Chemicals segment saw a 13% YoY volume increase, contributing 40% to the total revenue mix.
Suspension PVC business was impacted by the non-implementation of anti-dumping duties and rescinded Quality Control Orders.
R32 refrigerant gas expansion of 14 KTPA is underway, with the first 2 KTPA swing plant expected by the end of Q4 FY26.
Management maintains a long-term revenue guidance of ₹1,000 crores for the Custom Manufactured Chemicals division by FY27-28.
💼 Action for Investors
Investors should closely monitor PVC price spreads and the successful ramp-up of the R32 and CMC expansion projects to gauge a return to profitability. The impact of the Chinese export tax rebate withdrawal in April 2026 will be a critical catalyst for domestic margin recovery.
Chemplast Sanmar Q3 FY26: Revenue Drops 21% YoY to ₹835 Cr with Net Loss Widening to ₹119 Cr
Chemplast Sanmar reported a challenging Q3 FY26, with consolidated revenue declining 21% YoY to ₹835 Cr and a net loss of ₹119 Cr. The performance was severely impacted by pricing pressures in the Suspension PVC segment due to cheap imports and a global slowdown in the agrochemical sector affecting the Custom Manufacturing division. Despite the losses, management is optimistic about FY27, citing the withdrawal of Chinese export tax rebates and the upcoming commissioning of new R32 refrigerant gas and specialty chemical capacities. EBITDA margins turned negative at -7% for the quarter compared to 3% in the same period last year.
Key Highlights
Consolidated Revenue for Q3 FY26 fell 21% YoY to ₹835 Cr from ₹1,058 Cr in Q3 FY25.
Reported an EBITDA loss of ₹57 Cr in Q3 FY26 against a profit of ₹32 Cr in the previous year.
Net Loss widened significantly to ₹119 Cr for the quarter compared to a loss of ₹49 Cr in Q3 FY25.
9M FY26 EBITDA plummeted 98% YoY to ₹4 Cr, reflecting severe margin compression across product lines.
R32 refrigerant gas expansion to 14 ktpa and MPB-3 Phase 3 projects are on track for completion in Q4 FY26.
💼 Action for Investors
Investors should exercise caution as the company continues to report significant losses and faces pricing headwinds in its core PVC and caustic soda segments. While the upcoming capacity expansions and regulatory shifts in China offer a potential recovery path in FY27, it is advisable to wait for signs of bottoming out in margins before increasing exposure.
Chemplast Sanmar Q3 FY26 Standalone Revenue Drops 14% YoY; Reports Net Loss of ₹56.50 Cr
Chemplast Sanmar reported a weak performance for the quarter ended December 31, 2025, with standalone revenue from operations declining to ₹504.34 crore from ₹585.92 crore in the same quarter last year. The company posted a standalone net loss of ₹56.50 crore, a significant deterioration compared to the ₹29.75 crore loss in Q3 FY25 and a sharp reversal from the profit reported in the preceding quarter. Total expenses remained high at ₹583.44 crore, consistently exceeding total income. For the nine-month period, the standalone net loss has widened significantly to ₹120.45 crore compared to a loss of ₹40.36 crore in the previous year.
Key Highlights
Standalone revenue from operations fell 13.9% YoY to ₹504.34 crore in Q3 FY26.
Reported a standalone net loss of ₹56.50 crore for the quarter versus a loss of ₹29.75 crore in the year-ago period.
Nine-month standalone net loss widened to ₹120.45 crore from ₹40.36 crore in 9M FY25.
Total expenses for the quarter stood at ₹583.44 crore, resulting in a loss before tax of ₹76.73 crore.
Recorded a one-time incremental impact of ₹1.89 crore due to the assessment of New Labour Codes.
💼 Action for Investors
Investors should exercise caution as the company continues to face margin pressure and widening losses in its speciality chemicals business. Closely monitor the management's commentary on demand recovery and the impact of global chemical pricing on their bottom line.
Chemplast Sanmar Appoints S Ganeshkumar as MD for 3 Years Effective April 2026
Chemplast Sanmar Limited has announced a planned leadership transition where Mr. S Ganeshkumar will take over as Managing Director for a three-year term starting April 1, 2026. The current MD, Mr. Ramkumar Shankar, will serve a brief two-month extension until March 31, 2026, to ensure a smooth handover. Additionally, the company has reappointed four independent directors for a second five-year term, signaling continuity in corporate governance. Mr. Ganeshkumar brings extensive experience from TCI Sanmar Chemicals and Raymond Limited, which is expected to support the company's long-term strategic goals.
Key Highlights
Mr. S Ganeshkumar appointed as Managing Director for a 3-year term starting April 1, 2026.
Current MD Mr. Ramkumar Shankar granted a 2-month extension from February 1, 2026, to March 31, 2026.
Four Independent Directors reappointed for a second 5-year term beginning April 26, 2026.
Incoming MD has over 30 years of experience, including leadership roles at TCI Sanmar Chemicals and Raymond Limited.
💼 Action for Investors
Investors should view this as a well-planned succession that ensures stability; no immediate action is required as the transition is over a year away.
Chemplast Sanmar Appoints S Ganeshkumar as MD; Reappoints 4 Independent Directors
Chemplast Sanmar has announced a leadership transition with Mr. S Ganeshkumar appointed as Managing Director for a 3-year term starting April 1, 2026. The current MD, Mr. Ramkumar Shankar, will serve a brief 2-month extension until March 31, 2026, to facilitate a smooth handover at the close of the financial year. Furthermore, the board has approved the reappointment of four Independent Directors for a second five-year term beginning April 26, 2026. These appointments are subject to shareholder approval and aim to ensure long-term governance stability.
Key Highlights
Mr. S Ganeshkumar appointed as Managing Director for a 3-year term effective April 1, 2026
Current MD Mr. Ramkumar Shankar to step down on March 31, 2026, after a 2-month extension
Four Independent Directors reappointed for a second consecutive 5-year term starting April 26, 2026
Incoming MD S Ganeshkumar currently serves as CEO and MD of TCI Sanmar Chemicals S.A.E., Egypt
💼 Action for Investors
Investors should view this as a planned leadership transition with a focus on continuity, as the new MD comes from within the Sanmar group ecosystem. No immediate action is required, but monitoring the transition's impact on operational execution in FY27 is advised.